James Patrick Tursi is Chief Medical Officer at AUXILIUM PHARMACEUTICALS INC (AUXL). They have made 5 open-market trades across 2 companies since 2014, most recently 2026-06-08.
CIK 0001527710
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
3 open-market purchases totalling $65K since 2016, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ARLZ | SELL · 10b5-1 | 2018-05-14 | 2018-05-16 | $0.52 | $5K | -18.5% | -8.3% | -86.8% |
| ARLZ | SELL · 10b5-1 | 2018-03-19 | 2018-03-21 | $1.70 | $10K | -12.5% | -17.3% | -75.8% |
| ARLZ | SELL · 10b5-1 | 2017-10-02 | 2017-10-04 | $2.50 | $25K | -38.8% | -29.4% | -37.6% |
| ARLZ | BUY | 2017-03-15 | 2017-03-17 | $2.11 | $10K | -11.8% | -36.5% | -54.9% |
| ARLZ | BUY | 2016-05-20 | 2016-05-23 | $3.75 | $38K | -0.5% | -16.3% | +38.6% |
| ARLZ | BUY | 2016-05-16 | 2016-05-18 | $3.79 | $17K | +6.4% | -8.5% | +35.9% |
| AUXL | SELL | 2014-11-25 | 2014-11-26 | $34.12 | $468K | N/A | N/A | N/A |
| AUXL | SELL | 2014-11-20 | 2014-11-24 | $33.19 | $2.5M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.